%0 Generic
%A Morgensztern, D.
%A Govindan, R.
%A Cobo, M.
%A Ponce Aix, S.
%A Postmus, P. E.
%A Lewanski, C.
%A Bennouna, J.
%A Fischer, J.
%A Juan-Vidal, O.
%A Stewart, D.
%A Ardizzoni, A.
%A Bhore, R.
%A Wolfsteiner, M.
%A Reck, M.
%A Talbot, D.
%A Ong, T. J.
%T Efficacy and Safety of Second- or Third-Line Nab-Paclitaxel plus Durvalumab in Patients with Advanced NSCLC (ABOUND.2L+)
%D 2018
%@ 1556-0864
%U https://hdl.handle.net/10668/27914
%K nab-paclitaxel
%K survival
%K durvalumab
%~